[
  {
    "ts": null,
    "headline": "Raymond James Announces Pricing of Offering of $1.5 Billion of Senior Notes",
    "summary": "St. Petersburg, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Raymond James Financial, Inc. (NYSE: RJF) (“Raymond James” or the “Company”) today announced the pricing of a registered underwritten public offering of (i) $650,000,000 aggregate principal amount of 4.900% senior notes due 2035 (the “2035 Notes”) and (ii) $850,000,000 aggregate principal amount of 5.650% senior notes due 2055 (the “2055 Notes” and, together with the 2035 Notes, the “Notes”). The 2035 Notes will bear interest at a rate of",
    "url": "https://finnhub.io/api/news?id=69c2102dba5b35fb1aff9f78c60039981734766defe078706c5f678b1f5f3c0f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757460720,
      "headline": "Raymond James Announces Pricing of Offering of $1.5 Billion of Senior Notes",
      "id": 136690505,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RJF",
      "source": "Yahoo",
      "summary": "St. Petersburg, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Raymond James Financial, Inc. (NYSE: RJF) (“Raymond James” or the “Company”) today announced the pricing of a registered underwritten public offering of (i) $650,000,000 aggregate principal amount of 4.900% senior notes due 2035 (the “2035 Notes”) and (ii) $850,000,000 aggregate principal amount of 5.650% senior notes due 2055 (the “2055 Notes” and, together with the 2035 Notes, the “Notes”). The 2035 Notes will bear interest at a rate of",
      "url": "https://finnhub.io/api/news?id=69c2102dba5b35fb1aff9f78c60039981734766defe078706c5f678b1f5f3c0f"
    }
  },
  {
    "ts": null,
    "headline": "CVS defended by Raymond James after stock drop",
    "summary": "Investing.com -- Raymond James analysts defended CVS Health after the stock fell about 4.8% on Monday, saying the move reflected “misinterpretation” of industry commentary rather than any change in company fundamentals.",
    "url": "https://finnhub.io/api/news?id=0882cd31c185a8170a9b81dd106ee6d4ba12670d900c2bc5c903ebdbb394f37d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757439495,
      "headline": "CVS defended by Raymond James after stock drop",
      "id": 136687342,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RJF",
      "source": "Yahoo",
      "summary": "Investing.com -- Raymond James analysts defended CVS Health after the stock fell about 4.8% on Monday, saying the move reflected “misinterpretation” of industry commentary rather than any change in company fundamentals.",
      "url": "https://finnhub.io/api/news?id=0882cd31c185a8170a9b81dd106ee6d4ba12670d900c2bc5c903ebdbb394f37d"
    }
  }
]